FGF-FGFR Signaling in Cancer

Living reference work entry


Fibroblast growth factors (FGF) have pleiotropic roles in human development and metabolism, and FGF signaling through FGF receptors (FGFRs) has been implicated in a wide range of cancers. Extensive pre-clinical and clinical studies are currently underway to elucidate the therapeutic possibilities: monoclonal antibodies, ligand traps, heparanoids, and kinase inhibitors all have potential for the treatment of FGFR-driven cancers.


Brivanib Dovitinib FGF receptor (FGFR) Fibroblast growth factor (FGF) Aberrant FGF Signaling A-loop tyrosine phosphorylation Core homology region CRKL ELISA Endocrine FGFs Exon 8 and exon 9 FGFR binding specificity FGFR dimerization FGFR1–3 genes FRS2α, 3 Immunohistochemical staining Mechanisms Overexpression Paracrine-acting FGF subfamilies Preclinical studies Prognostic markers Pyruvate kinase Role in cancer Single nucleotide polymorphisms (SNPs) Somatic mutations Subfamilies Therapy Palifermin 


  1. Beenken A, Mohammadi M. The FGF family: biology, phathophysiology, and therapy. Nat Rev Drug Discov. 2009;8:235–53.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Beenken A, Mohammadi M. The molecular bases for FGF receptor activation in craniosynostosis and dwarfism syndromes. In: Muenke M, Kress W, Collmann H, Solomon BD, editors. Craniosynostoses: molecular genetics, principles of diagnosis, and treatment. Basel: Karger; 2011;45–57.Google Scholar
  3. Beenken A, Mohammadi M. The structural biology of the FGF19 subfamily. In: Kuro-o M, editor. Endocrine FGFs and Klothos. Austin, Texas: Landes Bioscience; Adv Exp Med Biol. 2012;728:1–24.Google Scholar
  4. Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005;16:233–47.CrossRefPubMedGoogle Scholar
  5. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16:139–49.CrossRefPubMedGoogle Scholar
  6. Ezzat S, Zheng L, Yu S, Asa SL. A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cells. Biochem Biophys Res Commun. 2001;287:60–5.CrossRefPubMedGoogle Scholar
  7. Fan J, Hitosugi T, Chung TW, Xie J, Ge Q, Gu TL, Polakiewicz RD, Chen GZ, Boggon TJ, Lonial S, Khuri FR, Kang S, Chen J. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells. Mol Cell Biol. 2011;31:4938–50.CrossRefPubMedPubMedCentralGoogle Scholar
  8. French DM, Lin BC, Wang M, Adams C, Shek T, Hotzel K, Bolon B, Ferrando R, Blackmore C, Schroeder K, Rodriguez LA, Hristopoulos M, Venook R, Ashkenazi A, Desnoyers LR. Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One. 2012;7:e36713.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14:166–80.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gotoh N. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci. 2008;99:1319–25.CrossRefPubMedGoogle Scholar
  11. Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ, Xie J, Gu TL, Polakiewicz RD, Roesel JL, Boggon TJ, Khuri FR, Gilliland DG, Cantley LC, Kaufman J, Chen J. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal. 2009;2, ra73.Google Scholar
  12. Johnson DE, Lu J, Chen H, Werner S, Williams LT. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol. 1991;11:4627–34.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Kim KB, Chesney J, Robinson D, Gardner H, Shi MM, Kirkwood JM. Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17:7451–61.CrossRefGoogle Scholar
  14. Knights V, Cook SJ. De-regulated FGF receptors as therapeutic targets in cancer. Pharmacol Ther. 2010;125:105–17.CrossRefPubMedGoogle Scholar
  15. Kuro-o M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol Metab. 2008;19:239–45.CrossRefPubMedGoogle Scholar
  16. Martin GR. The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 1998;12:1571–86.CrossRefPubMedGoogle Scholar
  17. Miyake M, Sugano K, Sugino H, Imai K, Matsumoto E, Maeda K, Fukuzono S, Ichikawa H, Kawashima K, Hirabayashi K, Kodama T, Fujimoto H, Kakizoe T, Kanai Y, Fujimoto K, Hirao Y. Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer. Cancer Sci. 2010;101:250–8.CrossRefPubMedGoogle Scholar
  18. Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 2005a;16:107–37.CrossRefPubMedGoogle Scholar
  19. Mohammadi M, Olsen SK, Goetz R. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Curr Opin Struct Biol. 2005b;15:506–16.CrossRefPubMedGoogle Scholar
  20. Ornitz DM. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 2005;16:205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Qing J, Du X, Chen Y, Chan P, Li H, Wu P, Marsters S, Stawicki S, Tien J, Totpal K, Ross S, Stinson S, Dornan D, French D, Wang QR, Stephan JP, Wu Y, Wiesmann C, Ashkenazi A. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. J Clin Invest. 2009;119:1216–29.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, Zhao A, Busuttil RW, Yee H, Stein L, French DM, Finn RS, Lowe SW, Powers S. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell. 2011;19:347–58.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211–25.CrossRefPubMedGoogle Scholar
  24. Seo JH, Suenaga A, Hatakeyama M, Taiji M, Imamoto A. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Mol Cell Biol. 2009;29:3076–87.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590–8.CrossRefPubMedGoogle Scholar
  26. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10:116–29.CrossRefPubMedGoogle Scholar
  27. Wang H, Venkatesh M, Li H, Goetz R, Mukherjee S, Biswas A, Zhu L, Kaubisch A, Wang L, Pullman J, Whitney K, Kuro-o M, Roig AI, Shay JW, Mohammadi M, Mani S. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest. 2011;121:3220–32.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Wilkie AO. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 2005;16:187–203.CrossRefPubMedGoogle Scholar
  29. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15–33.CrossRefPubMedGoogle Scholar
  30. Yu X, White KE. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 2005;16:221–32.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of PharmacologyNYU Medical CenterNew YorkUSA
  2. 2.Internal MedicineNew York Presbyterian Hospital, Columbia University Medical CenterNew YorkUSA

Personalised recommendations